Surgical options are limited for high-risk patients with mitral annual calcification (MAC). But researchers are discovering that transcatheter mitral valve replacement might be an option for carefully selected patients, says Dr. Mayra Guerrero of NorthShore University HealthSystem at Piedmont Heart’s iMAGINE 2015 meeting